| Literature DB >> 35909173 |
Katarzyna Sikorska1, Marta Gesing2, Romuald Olszański3, Anna Roszko-Wysokińska3, Beata Szostakowska4, Katarzyna Van Damme-Ostapowicz5.
Abstract
BACKGROUND: Leishmaniasis is a widespread disease in tropical and subtropical countries, except for Australia and Oceania. In Poland, tourists, migrants and travellers from leishmaniasis-endemic countries may carry Leishmania. CASEEntities:
Keywords: Case report; Cutaneous leishmaniasis; Diagnosis; PCR; Travel; Treatment
Year: 2022 PMID: 35909173 PMCID: PMC9341103 DOI: 10.1186/s40794-022-00175-5
Source DB: PubMed Journal: Trop Dis Travel Med Vaccines ISSN: 2055-0936
Fig. 1.Non-painful ulceration covered by a 2 × 1 cm scab on erythematous in the right submandibular region five months after the onset of symptoms
Fig. 2.Eight months after the onset of symptoms, the ulceration had enlarged (10× 5 cm); it had an erythematous base and was covered with fibropurulent exudate and a thick scab on the periphery
Fig. 3.Nine months after symptom onset, the ulcer was large; it had an erythematous base and was covered with fibropurulent exudate and a thick scab on the periphery
Fig. 4.After cutaneous leishmaniasis was diagnosed the treatment were introduced; antimony derivatives (Glucantime 30 ampoules), local cryotherapy and 2% Argosulfan cream
Fig. 5.During treatment, there was visible gradual improvement
Fig. 6.After treatment with antimony, the lesions healed but left an unsightly scar